drugset

drugset / Trial / NCT00292929

Study of the Safety of Intravenous Artesunate

NCT00292929 ↗

Phase 1 Completed 40 enrolled U.S. Army Medical Research and Development Command

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to establish the safety, tolerability and pharmacokinetics of a single dose of the antimalarial drug artesunate.

Timeline

Start: —
Primary completion: —
Completion: 2006-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Artesunate	Small molecule	—	Intravenous

Indications